Insulin Degludec Titration Using Mobile Insulin Dosing System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

Also called NCT03091712

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 240 participants (enrolled count) (from the registry)
Sponsor
Glooko (from the registry)
Registry
  • NCT NCT03091712
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03091712. Randomized; no masking; primary purpose treatment. Start 2017-05-05 (actual); primary completion 2019-08-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Insulin Degludec Titration Using Mobile Insulin Dosing System
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Glooko Mobile Insulin Dosing System(MIDS)
Lead sponsor
Glooko (class: industry)

Record details

Record id
cardio:ct-nct03091712
Content hash
3c33e637fe4761b5e46d2426cf6284540b48463168428745a437f2acedfcfebc